DT
Denali Therapeutics Inc
🇩🇪XSTU.4DNGermanyHealthcare
€17.62EURdown -0.75 (-4.08%)OpenEnd of day5:40 PM
Price€17.62-0.75 (-4.08%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US24823R1059
- CUSIP
- Not reported
Company
- Employees
- 503
- Headquarters
- South San Francisco, United States
- CEO
- Dr. Ryan J. Watts Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3.6M+100%up year on year
- Net income
- -$511.45M-6.77%down year on year
- Gross margin
- -2,889.84%
- Free cash flow
- -$437.46M-18.89%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.